CA2779838A1 - Traitement des etats provoques par la cytokine - Google Patents

Traitement des etats provoques par la cytokine Download PDF

Info

Publication number
CA2779838A1
CA2779838A1 CA 2779838 CA2779838A CA2779838A1 CA 2779838 A1 CA2779838 A1 CA 2779838A1 CA 2779838 CA2779838 CA 2779838 CA 2779838 A CA2779838 A CA 2779838A CA 2779838 A1 CA2779838 A1 CA 2779838A1
Authority
CA
Canada
Prior art keywords
gag
heparin
sulfated
treatment
depolymerised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2779838
Other languages
English (en)
Inventor
Erik Eklund
Gunvor Ekman-Ordeberg
Anders Malmstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dilafor AB
Original Assignee
Dilafor AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor AB filed Critical Dilafor AB
Priority to CA 2779838 priority Critical patent/CA2779838A1/fr
Publication of CA2779838A1 publication Critical patent/CA2779838A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2779838 2012-06-14 2012-06-14 Traitement des etats provoques par la cytokine Abandoned CA2779838A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2779838 CA2779838A1 (fr) 2012-06-14 2012-06-14 Traitement des etats provoques par la cytokine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2779838 CA2779838A1 (fr) 2012-06-14 2012-06-14 Traitement des etats provoques par la cytokine

Publications (1)

Publication Number Publication Date
CA2779838A1 true CA2779838A1 (fr) 2013-12-14

Family

ID=49753565

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2779838 Abandoned CA2779838A1 (fr) 2012-06-14 2012-06-14 Traitement des etats provoques par la cytokine

Country Status (1)

Country Link
CA (1) CA2779838A1 (fr)

Similar Documents

Publication Publication Date Title
Pomin Sulfated glycans in inflammation
CA2326510C (fr) Formulations de dextrane et procede servant a traiter des troubles articulaires inflammatoires
EP2786782B1 (fr) Acide hyaluronique sulfaté destiné au traitement de l'arthrose dégénérative
US20070054878A1 (en) Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis
ES2367778T3 (es) Derivados de glucosaminoglucanos parcialmente desulfatados como inhibidores de heparanasa, provistos de actividad antiangiogénica y desprovistos de efecto anticoagulante.
US8524688B2 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
JP5636225B2 (ja) 炎症性腸疾患（ｉｂｄ）の治療及び予防に使用するための医薬組成物
CA2868444A1 (fr) Traitement combine comprenant des glycosaminoglycanes sulfates pour l'induction du travail
EP1731131A1 (fr) Accelerateur de production hgf contenant un oligosaccharide de type heparine
US20100331746A1 (en) Method of using enoxaparin for reducing the risk of death in acutely ill medical patients
JPH08277224A (ja) 抗炎症剤
CA2645982A1 (fr) Utilisation de l'ave5026 pour reduire la frequence des saignements durant un traitement antithrombotique
AU2012203519A1 (en) Treatment of cytokine mediated conditions
CA2779838A1 (fr) Traitement des etats provoques par la cytokine
Ling et al. Effects of a hyaluronic acid and low molecular weight heparin injection on osteoarthritis in rabbits.
GARG et al. Hyaluronan in Ventilator-Induced Lung Injury
AU2009200642A1 (en) Method using enoxaparin for reducing the risk of death in acutely ill medical patients

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20150616